Cystic Fibrosis Market
Cystic Fibrosis Market - Global Industry Assessment & Forecast
#
Pages:
250
Base Year:
2023
Oct - 2024
Format:
Report Code:
VMR-2777
Segments Covered
By
Drug Class Cystic Fibrosis Transmembrane Conductane Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, Others
-
By
Route of Administration Oral, Inhalation, Injectable, Others
-
By
Distribution Channel Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 10.4 Billion |
 Revenue 2032:
|
USD 55.4 Billion |
 Revenue CAGR
(2024 - 2032): |
21.6% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cystic Fibrosis Market Segment Analysis
- Cystic Fibrosis Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Cystic Fibrosis Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Inhalation
- Injectable
- Others
- Cystic Fibrosis Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
-
North America Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
-
North America Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- U.S.
- U.S. Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- U.S. Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- U.S. Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- U.S. Cystic Fibrosis Market, by Drug Class
- Canada
- Canada Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Canada Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Canada Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Canada Cystic Fibrosis Market, by Drug Class
-
Mexico
- Mexico Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Mexico Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Mexico Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Mexico Cystic Fibrosis Market, by Drug Class
-
North America Cystic Fibrosis Market, by Drug Class
- Europe
-
Europe Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
-
Europe Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
-
Europe Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- U. K.
- U.K. Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- U.K. Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- U.K. Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- U.K. Cystic Fibrosis Market, by Drug Class
- France
- France Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- France Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- France Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- France Cystic Fibrosis Market, by Drug Class
-
Germany
- Germany Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Germany Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Germany Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Germany Cystic Fibrosis Market, by Drug Class
-
Italy
- Italy Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Italy Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Italy Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Italy Cystic Fibrosis Market, by Drug Class
-
Spain
- Spain Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Spain Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Spain Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Spain Cystic Fibrosis Market, by Drug Class
-
Rest of Europe
- Rest of Europe Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Rest of Europe Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Rest of Europe Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Rest of Europe Cystic Fibrosis Market, by Drug Class
-
Europe Cystic Fibrosis Market, by Drug Class
- Asia Pacific
-
Asia Pacific Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
-
Asia Pacific Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
-
Asia Pacific Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- China
- China Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- China Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- China Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- China Cystic Fibrosis Market, by Drug Class
- Japan
- Japan Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Japan Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Japan Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Japan Cystic Fibrosis Market, by Drug Class
-
Germany
- Germany Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Germany Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Germany Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Germany Cystic Fibrosis Market, by Drug Class
-
India
- India Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- India Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- India Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- India Cystic Fibrosis Market, by Drug Class
-
South Korea
- South Korea Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- South Korea Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- South Korea Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- South Korea Cystic Fibrosis Market, by Drug Class
-
South East Asia
- South East Asia Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- South East Asia Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- South East Asia Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- South East Asia Cystic Fibrosis Market, by Drug Class
-
Rest of Asia Pacific
- Rest of Asia Pacific Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Rest of Asia Pacific Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Rest of Asia Pacific Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Rest of Asia Pacific Cystic Fibrosis Market, by Drug Class
-
Asia Pacific Cystic Fibrosis Market, by Drug Class
- Latin America
-
Latin America Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
-
Latin America Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
-
Latin America Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Brazil
- Brazil Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Brazil Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Brazil Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Brazil Cystic Fibrosis Market, by Drug Class
- Argentina
- Argentina Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Argentina Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Argentina Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Argentina Cystic Fibrosis Market, by Drug Class
-
Rest of Latin America
- Rest of Latin America Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Rest of Latin America Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Rest of Latin America Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Rest of Latin America Cystic Fibrosis Market, by Drug Class
-
Latin America Cystic Fibrosis Market, by Drug Class
- Middle East & Africa
-
Middle East & Africa Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
-
Middle East & Africa Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
-
Middle East & Africa Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- GCC Countries
- GCC Countries Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- GCC Countries Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- GCC Countries Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- GCC Countries Cystic Fibrosis Market, by Drug Class
- South Africa
- South Africa Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- South Africa Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- South Africa Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- South Africa Cystic Fibrosis Market, by Drug Class
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cystic Fibrosis Market, by Drug Class
- Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Rest of Middle East & Africa Cystic Fibrosis Market, by Route of Administration
- Oral
- Inhalation
- Injectable
- Others
- Rest of Middle East & Africa Cystic Fibrosis Market, by Distribution Channel
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Rest of Middle East & Africa Cystic Fibrosis Market, by Drug Class
-
Middle East & Africa Cystic Fibrosis Market, by Drug Class
- North America
FAQ
Frequently Asked Question
What is the global demand for Cystic Fibrosis in terms of revenue?
-
The global Cystic Fibrosis valued at USD 10.4 Billion in 2023 and is expected to reach USD 55.4 Billion in 2032 growing at a CAGR of 21.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Vertex Pharmaceuticals Incorporated, AbbVie Inc., Gilead Sciences, Inc., Genentech, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Perrigo Company plc, Pharmaxis Ltd., Celtaxsys, Inc., Savara Inc., Kamada Ltd., Chiesi Farmaceutici S.p.A., Galapagos NV, Proteostasis Therapeutics, Inc., Eloxx Pharmaceuticals, Inc., Insmed Incorporated, Arcturus Therapeutics Holdings Inc., Translate Bio, Inc.,Zogenix, Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 21.6% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cystic Fibrosis include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cystic Fibrosis in 2023.
